Country: United States
Language: English
Source: NLM (National Library of Medicine)
URSODIOL (UNII: 724L30Y2QR) (URSODIOL - UNII:724L30Y2QR)
Mylan Pharmaceuticals Inc.
URSODIOL
URSODIOL 300 mg
ORAL
PRESCRIPTION DRUG
Ursodiol Capsules, USP are a bile acid available as 300 mg capsules suitable for oral administration. Ursodiol, USP (ursodeoxycholic acid) is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. It is a white or almost white crystalline powder freely soluble in alcohol and in glacial acetic acid, slightly soluble in acetone, methylene chloride, and ether, sparingly soluble in chloroform, and practically insoluble in water. The chemical name for ursodiol is 3α,7β-Dihydroxy-5β-cholan-24-oic acid (C24 H40 O4 ). Ursodiol has a molecular weight of 392.57. Its structure is shown below: Each capsule contains 300 mg of ursodiol, USP with the following inactive ingredients: colloidal silicon dioxide, corn starch, FD&C Yellow No. 6, gelatin, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, sodium starch glycolate and titanium dioxide. The imprinting ink contains the following: black iron oxide, D&C Yellow
Ursodiol Capsules, USP are available containing 300 mg of ursodiol, USP. The 300 mg capsules are hard-shell gelatin capsules with a peach opaque cap and a white opaque body filled with white to off-white powder. The capsule is axially printed with MYLAN over 1730 in black ink on both the cap and body. They are available as follows: NDC 0378-1730-01 bottles of 100 capsules Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Revised: 5/2020 USDL:R4
Abbreviated New Drug Application
URSODIOL- URSODIOL CAPSULE MYLAN PHARMACEUTICALS INC. ---------- SPECIAL NOTE Gallbladder stone dissolution with ursodiol treatment requires months of therapy. Complete dissolution does not occur in all patients and recurrence of stones within 5 years has been observed in up to 50% of patients who do dissolve their stones on bile acid therapy. Patients should be carefully selected for therapy with ursodiol, and alternative therapies should be considered. DESCRIPTION Ursodiol Capsules, USP are a bile acid available as 300 mg capsules suitable for oral administration. Ursodiol, USP (ursodeoxycholic acid) is a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. It is a white or almost white crystalline powder freely soluble in alcohol and in glacial acetic acid, slightly soluble in acetone, methylene chloride, and ether, sparingly soluble in chloroform, and practically insoluble in water. The chemical name for ursodiol is 3α,7β-Dihydroxy-5β-cholan-24-oic acid (C H O ). Ursodiol has a molecular weight of 392.57. Its structure is shown below: Each capsule contains 300 mg of ursodiol, USP with the following inactive ingredients: colloidal silicon dioxide, corn starch, FD&C Yellow No. 6, gelatin, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, sodium starch glycolate and titanium dioxide. The imprinting ink contains the following: black iron oxide, D&C Yellow No. 10 Aluminum Lake, FD&C Blue No. 1 Aluminum Lake, FD&C Blue No. 2 Aluminum Lake, FD&C Red No. 40 Aluminum Lake, propylene glycol and shellac glaze. CLINICAL PHARMACOLOGY About 90% of a therapeutic dose of ursodiol is absorbed in the small bowel after oral administration. After absorption, ursodiol enters the portal vein and undergoes efficient extraction from portal blood by the liver (i.e., there is a large “first-pass” effect) where it is conjugated with either glycine or taurine and is then secreted into the hepatic bile ducts. Ursodiol i Read the complete document